• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

EXATECAN MESYLATE Drug Record

  • Summary
  • Interactions
  • Claims
  • EXATECAN MESYLATE chembl:CHEMBL3989759

    Alternate Names:

    EXATECAN METHANESULFONATE DIHYDRATE
    EXATECAN MESILATE HYDRATE
    EXATECAN MESILATE DIHYDRATE
    DX-8951F
    EXATECAN MESYLATE

    Drug Info:

    (0 More Sources)

    Publications:

    Okamoto et al., 2002, O(6)-methylguanine-DNA methyltransferase (MGMT) as a determinant of resistance to camptothecin derivatives., Jpn. J. Cancer Res.
    Okamura et al., 2000, NADPH/quinone oxidoreductase is a priority target of glioblastoma chemotherapy., Int. J. Oncol.
  • EXATECAN MESYLATE   MGMT

    Interaction Score: 3.25

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    11802813


    Sources:
    NCI

  • EXATECAN MESYLATE   GSTP1

    Interaction Score: 1.29

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    10639573


    Sources:
    NCI

  • NCI: DX-8951F

    • Version: 14-September-2017

    Alternate Names:
    C1679 NCI drug code

    Drug Info:

    Publications:
    Okamura et al., 2000, NADPH/quinone oxidoreductase is a priority target of glioblastoma chemotherapy., Int. J. Oncol.
    Okamoto et al., 2002, O(6)-methylguanine-DNA methyltransferase (MGMT) as a determinant of resistance to camptothecin derivatives., Jpn. J. Cancer Res.

  • ChemblDrugs: chembl:CHEMBL3989759

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21